Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.82 USD | -0.58% | -2.89% | -10.62% |
05-14 | Transcript : OptimizeRx Corporation, Q1 2024 Earnings Call, May 14, 2024 | |
05-14 | OptimizeRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.62% | 235M | |
+30.93% | 456B | |
+31.76% | 280B | |
+6.03% | 134B | |
+29.89% | 94.31B | |
+5.43% | 91.48B | |
+59.15% | 60.48B | |
+13.67% | 46.13B | |
+25.91% | 37.31B | |
+0.15% | 35.48B |
- Stock Market
- Equities
- OPRX Stock
- News OptimizeRx Corporation
- Stifel Adjusts Price Target on OptimizeRx to $13 From $16, Maintains Buy Rating